Please note that a publication can be assigned to several endpoints, i.e. the sum of publications from the individual thematic points and subpoints can be greater than the total sum of actual publications.
Authors | Year | Exposed system | Parameters | Magnetic flux density/field strength |
---|---|---|---|---|
Reipert BM et al. | 1997 | intact cell/cell culture, FDCP-mix(A4) cell line (mouse bone marrow cells) | magnetic field, static magnetic field, 50/60 Hz, shielding/field deprivation | 0.2 µT–2 mT |
Ruiz-Gomez MJ et al. | 2010 | intact cell/cell culture, yeast (<i>Saccharomyces cerevisiae</i>)/WS8105-1C (genotype <i>MATalpha, ade2, arg4-17, trp1-289, ura3-52</i>: a marker which stains the colonies red) | magnetic field, static magnetic field, 50/60 Hz, DC | 0.35–2.45 mT |
Saikia J et al. | 2019 | isolated bio./chem. substance, beta-amyloid protein | electric field, magnetic field, 50/60 Hz, static electric field | - |
Sakurai T et al. | 2008 | intact cell/cell culture, HIT-T15 cells (hamster-derived insulin-secreting cell line) | magnetic field, low frequency, 50/60 Hz | 5 mT |
Salek F et al. | 2021 | intact cell/cell culture | magnetic field, 50/60 Hz, co-exposure, also other exposures without EMF | 2.5 mT |
Samiei M et al. | 2020 | intact cell/cell culture, human dental pulp stem cells | magnetic field, 50/60 Hz | 0.5–1 mT |
Sanie-Jahromi F et al. | 2016 | intact cell/cell culture, MCF-7 (human breast cancer cell line) and SH-SY5Y (human neuroblastoma cell line) | magnetic field, 50/60 Hz, co-exposure | 0.25–0.5 mT |
Sanie-Jahromi F et al. | 2017 | - | magnetic field, 50/60 Hz, co-exposure | - |
Schimmelpfeng J | 1997 | intact cell/cell culture, HL-60 (human promyelocytic leukemia cells) | magnetic field, 50/60 Hz, co-exposure | 2 mT |
Schimmelpfeng J et al. | 1997 | intact cell/cell culture, SV40-swiss-3T3 cells (mouse fibroblast cell line) and HL-60 cells (human acute myeloid leukaemia cell line) | magnetic field, 50/60 Hz | 2 mT |
This website uses cookies to provide you the best browsing experience. By continuing to use this website you accept our use of cookies.